GRI Bio, Inc.
GRINASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $2.53M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.36$64.12
- Volume (live)
- -
- Avg. volume (3M)
- 350.87K
GRI Bio (GRI) Stock Price & Financial Analysis
GRI Bio Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.37 - $1.56 |
|---|---|
| 52-Week High | $64.12 |
| 52-Week Low | $1.36 |
| Open | $1.49 |
| Volume (last close) | 44.31K |
| Average Volume (3M) | 350.87K |
| 50-Day MA | $1.87 |
|---|---|
| 200-Day MA | $2.59 |
| 1-Year Change | −27.84% |
| Market Cap | 2.53M |
|---|---|
| Shares Outstanding | 1.80M |
| Price to Book (P/B) | 0.25 |
| EV/EBITDA | 0.87 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
GRI Bio at a Glance
As of the Oct 16, 2026 close, GRI Bio (GRI) has a market capitalization of $2.53M.
As of its latest reported balance sheet, it holds $10.95M in cash and securities against $44.00K of debt, a net cash position of $10.90M.
GRI Bio does not currently pay a dividend.
The share price is down 27.8% over the past year. At $1.38 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $1.36 to $64.12, below its 200-day moving average of $2.59.
Based on 1 professional analyst rating from the past 90 days, the consensus is Buy.
Frequently Asked Questions About GRI Bio
What is the current stock price for GRI?
As of the Oct 16, 2026 close, GRI stock trades at $1.38. The 52-week range is $1.36–$64.12, with a day range of $1.37–$1.56.
What is the P/E ratio for GRI?
The P/E ratio (Price-to-Earnings) for GRI is shown in the Key Statistics section. This valuation metric helps compare GRI Bio, Inc. to industry peers.
Does GRI pay dividends?
GRI Bio does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for GRI?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for GRI is Buy.
What is the market cap of GRI?
As of the Oct 16, 2026 close, GRI Bio's market capitalization is $2.5M, classifying it as a micro-cap company. GRI Bio operates in the Healthcare sector within the Biotechnology industry.